Blog
About

110
views
0
recommends
+1 Recommend
2 collections
    2
    shares
      • Record: found
      • Abstract: found
      • Article: found

      The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Annual Review of Public Health, 36(1), 559-574

          Related collections

          Most cited references 59

          • Record: found
          • Abstract: not found
          • Article: not found

          Medication-assisted therapies--tackling the opioid-overdose epidemic.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The changing face of heroin use in the United States: a retrospective analysis of the past 50 years.

            Over the past several years, there have been a number of mainstream media reports that the abuse of heroin has migrated from low-income urban areas with large minority populations to more affluent suburban and rural areas with primarily white populations.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Patterns of abuse among unintentional pharmaceutical overdose fatalities.

               Aron Hall (2008)
              Use and abuse of prescription narcotic analgesics have increased dramatically in the United States since 1990. The effect of this pharmacoepidemic has been most pronounced in rural states, including West Virginia, which experienced the nation's largest increase in drug overdose mortality rates during 1999-2004. To evaluate the risk characteristics of persons dying of unintentional pharmaceutical overdose in West Virginia, the types of drugs involved, and the role of drug abuse in the deaths. Population-based, observational study using data from medical examiner, prescription drug monitoring program, and opiate treatment program records. The study population was all state residents who died of unintentional pharmaceutical overdoses in West Virginia in 2006. Rates and rate ratios for selected demographic variables. Prevalence of specific drugs among decedents and proportion that had been prescribed to decedents. Associations between demographics and substance abuse indicators and evidence of pharmaceutical diversion, defined as a death involving a prescription drug without a documented prescription and having received prescriptions for controlled substances from 5 or more clinicians during the year prior to death (ie, doctor shopping). Of 295 decedents, 198 (67.1%) were men and 271 (91.9%) were aged 18 through 54 years. Pharmaceutical diversion was associated with 186 (63.1%) deaths, while 63 (21.4%) were accompanied by evidence of doctor shopping. Prevalence of diversion was greatest among decedents aged 18 through 24 years and decreased across each successive age group. Having prescriptions for a controlled substance from 5 or more clinicians in the year prior to death was more common among women (30 [30.9%]) and decedents aged 35 through 44 years (23 [30.7%]) compared with men (33 [16.7%]) and other age groups (40 [18.2%]). Substance abuse indicators were identified in 279 decedents (94.6%), with nonmedical routes of exposure and illicit contributory drugs particularly prevalent among drug diverters. Multiple contributory substances were implicated in 234 deaths (79.3%). Opioid analgesics were taken by 275 decedents (93.2%), of whom only 122 (44.4%) had ever been prescribed these drugs. The majority of overdose deaths in West Virginia in 2006 were associated with nonmedical use and diversion of pharmaceuticals, primarily opioid analgesics.
                Bookmark

                Author and article information

                Affiliations
                [1 ] Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts 02454; email: , , ,
                [2 ] Phoenix House Foundation, New York, NY 10023
                [3 ] Global Institute of Public Health, New York University, New York, NY 10003
                [4 ] Department of History, University of North Florida, Jacksonville, Florida 32224; email:
                [5 ] Center for Drug Safety and Effectiveness,
                [6 ] Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 21205; email:
                [7 ] Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, Maryland 21205; email:
                Journal
                Annual Reviews
                2015
                18 March 2015
                23 June 2017
                10.1146/ANNUREV-PUBLHEALTH-031914-122957
                25581144

                Comments

                Comment on this article